| Product NDC: | 0206-8862 |
| Proprietary Name: | Zosyn |
| Non Proprietary Name: | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
| Active Ingredient(s): | 4; 500 g/100mL; mg/100mL & nbsp; PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0206-8862 |
| Labeler Name: | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050750 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980301 |
| Package NDC: | 0206-8862-02 |
| Package Description: | 12 BAG in 1 BOX (0206-8862-02) > 100 mL in 1 BAG (0206-8862-01) |
| NDC Code | 0206-8862-02 |
| Proprietary Name | Zosyn |
| Package Description | 12 BAG in 1 BOX (0206-8862-02) > 100 mL in 1 BAG (0206-8862-01) |
| Product NDC | 0206-8862 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19980301 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 4; 500 |
| Strength Unit | g/100mL; mg/100mL |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |